Polymer-lipid hybrid nanoparticles incorporating green coffee extract: enhancing treatment for hepatic steatosis and fibrosis through metabolomic insights
Marco A. Uriostegui-Campos, Shaula A. Castro-Murrieta, Ximena I. Lopez-Cesati, Ricardo Colín-Delgado, Gabriela I. Carballo-López, Karla Cervantes-Luevano, Aldo Moreno-Ulloa, Ana B. Castro-Ceseña · 2025
Read Polymer-lipid hybrid nanoparticles incorporating green coffee extract: enhancing treatment for hepatic steatosis and fibrosis through metabolomic insights by Marco A. Uriostegui-Campos, Shaula A. Castro-Murrieta, Ximena I. Lopez-Cesati, Ricardo Colín-Delgado, Gabriela I. Carballo-López, Karla Cervantes-Luevano, Aldo Moreno-Ulloa, Ana B. Castro-Ceseña (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12658880.txt.
Description
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults globally. Its severe form, metabolic dysfunction-associated steatohepatitis (MASH), results in liver damage due to a combination of steatosis and fibrosis. Green coffee extract (GCE) derived from unroasted coffee beans demonstrates therapeutic potential for MASLD/MASH attributed to its rich profile of bioactive compounds.
Catalog record
| CREATOR | Marco A. Uriostegui-Campos, Shaula A. Castro-Murrieta, Ximena I. Lopez-Cesati, Ricardo Colín-Delgado, Gabriela I. Carballo-López, Karla Cervantes-Luevano, Aldo Moreno-Ulloa, Ana B. Castro-Ceseña |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |